Mayo Clinic: Obese Patients With HER2-Positive Breast Cancer May Have Worse Outcomes
12/11/2011
Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, Mayo Clinic researchers found in a study presented today at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. HER2-positive breast cancer gets its name from a protein called human epidermal growth factor receptor 2 that promotes cancer cell growth...
First Genome Sequencing Clinical Trial For Triple Negative Cancer Points To New Treatments
12/11/2011
Initial results from an ongoing clinical trial, the first designed to examine the utility of whole-genome sequencing for triple negative breast cancer, were reported during the CRTC-AACR San Antonio Breast Cancer Symposium. The results indicate activation of targets not previously associated with triple negative disease and could point toward new treatment strategies...
Breast Cancer Survival In Younger Breast Cancer Patients Improves With Bone Drug
12/10/2011
Zometa (zoledronic acid), used to protect bone health in pre-menopausal ER-Positive breast cancer patients, has been found to improve survival considerably. In fact, it had as beneficial an effect on survival as chemotherapy, researchers from the University of Vienna, Austria, reported in the 2011 CTRC-AACR San Antonio Breast Cancer Symposium this week...
Hemophilia B - Single Gene Therapy Treatment Offers Significant Improvement
12/10/2011
Patients with hemophilia B experienced considerable improvements and fewer injections with clotting factor to reduce bleeding after receiving just one treatment with gene therapy, researchers from St. Jude Children's Research Hospital, Memphis, USA, and University College London (UCL), England, reported in NEJM (New England Journal of Medicine)...
Breast Cancer Prevention - Part Time Low Carb Diet Better Than Standard Full Time Diets
12/10/2011
Women who go on a low carb diet just two days per week have a lower risk of developing breast cancer compared to those who follow a standard calorie-restricted diet every day of the week, in order to lose weight and lower their insulin blood levels. Long-term high blood insulin levels are known to raise cancer risk...
Researchers Identify A Novel Therapeutic Approach For Liver Cancer
12/10/2011
Cancer of the liver rare in the United States but the third-leading cause of cancer death worldwide can result from environmental exposures or infections like chronic hepatitis, but the link is poorly understood. Now, researchers at Dana-Farber Cancer Institute have identified a mechanism in mice that triggers inflammation in the liver and transforms normal cells into cancerous ones...
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from ongoing Phase II clinical trials of Puma's investigational drug PB272 (neratinib) were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium that is currently taking place in San Antonio, Texas...
Starch Intake May Influence Risk For Breast Cancer Recurrence
12/10/2011
Researchers have linked increased starch intake to a greater risk for breast cancer recurrence, according to results presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011. "The results show that it's not just overall carbohydrates, but particularly starch," said Jennifer A. Emond, M.S...
Recognizing Blood Poisoning Quickly
12/10/2011
Speed can save lives especially in the case of blood poisoning. The more quickly and directly doctors recognize and treat sepsis, the greater the patient's chances of survival. With the help of a new biochip, physicians will now be able to analyze blood within their own practice...
Study Sheds Light On Cancer Burden In Australia
12/10/2011
Over the past quarter century in Australia, cancer incidence rates have increased while deaths from cancer have steadily decreased. Those are some of the findings of a recent study published early online in the Asia-Pacific Journal of Clinical Oncology...